Trial re-evaluates routine defibrillator implantation after myocardial infarction
ESC Congress 2023 Is the routine implantation of an implantable cardioverter defibrillator (ICD) in myocardial infarction survivors with heart failure still an adequate therapy for prevention of sudden cardiac death? The PROFID EHRA trial is set to answer this question in a large, multicentre, EU-funded study. The consortium of partners and colleagues involved in the […]
